← Back to patent-cliff list
CAS 351227-63-9
di-tert-butyl ((((2R,3R)-3-(4-(4-cyanophenyl)thiazol-2-yl)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-yl)oxy)methyl) phosphate
Codes：FOSR-003
Application context (from source-drug indications)
甲癣Fosravuconazole L-Lysine Ethanolate美洲锥虫病Fosravuconazole L-Lysine Ethanolate
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Fosravuconazole L-Lysine EthanolateFosravuconazole L-Lysine Ethanolate | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
4-(2-((2R,3R)-3-(2,4-difluorophenyl)-3-hydroxy-4-(1H-1,2,4-triazol-1-yl)butan-2-yl)thiazol-4-yl)benzonitrile→di-tert-butyl (chloromethyl) phosphate→di-tert-butyl ((((2R,3R)-3-(4-(4-cyanophenyl)thiazol-2-yl)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-yl)oxy)methyl) phosphate
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.